HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B.

Abstract
Hepatitis B virus (HBV) genotype D and hepatitis B e antigen (HBeAg) negative chronic hepatitis are the most prevalent in Mediterranean countries. No data have ever been published on their prevalence in Syria, a country of intermediate endemicity for HBV. The aims of the current study were to determine the HBV genotype distribution in Syria, the prevalence of HBeAg-positive and HBeAg-negative chronic hepatitis and to analyse the clinical characteristics of each group. A total of 220 patients were included. Ninety-seven percent of the patients were of genotype D, and 72% were HBeAg negative. The HBeAg-negative patients were older, had a lower viral load, had more cirrhosis and the mode of contamination was known less than for HBeAg-positive patients. These findings have major implications in understanding the natural history of the infection and are of great relevance in the choice of therapy.
AuthorsN Antaki, S Haffar, S Ali Deeb, F Assaad, R Abou Harb, N Zeibane, M Nasserelddine, N Ibrahim, N Alhaj, E Jabbour, R Aaraj, F Antaki, K Kebbewar, Syrian Working Group for the Study of Viral Hepatitis
JournalEpidemiology and infection (Epidemiol Infect) Vol. 138 Issue 1 Pg. 40-4 (Jan 2010) ISSN: 1469-4409 [Electronic] England
PMID19538827 (Publication Type: Journal Article)
Chemical References
  • Hepatitis B e Antigens
Topics
  • Adult
  • Age Distribution
  • Female
  • Genotype
  • Hepatitis B e Antigens (blood)
  • Hepatitis B virus (classification, genetics)
  • Hepatitis B, Chronic (blood, epidemiology, virology)
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Sex Distribution
  • Syria (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: